1. Home
  2. RCI vs RPRX Comparison

RCI vs RPRX Comparison

Compare RCI & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rogers Communication Inc.

RCI

Rogers Communication Inc.

HOLD

Current Price

$37.58

Market Cap

21.1B

ML Signal

HOLD

Logo Royalty Pharma plc

RPRX

Royalty Pharma plc

HOLD

Current Price

$39.74

Market Cap

16.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCI
RPRX
Founded
1960
1996
Country
Canada
United States
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.1B
16.2B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
RCI
RPRX
Price
$37.58
$39.74
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
$34.50
$46.00
AVG Volume (30 Days)
894.8K
4.3M
Earning Date
10-23-2025
11-05-2025
Dividend Yield
3.81%
2.21%
EPS Growth
341.45
N/A
EPS
8.96
1.75
Revenue
$15,091,643,989.00
$2,349,844,000.00
Revenue This Year
$7.45
$37.13
Revenue Next Year
$5.57
$1.48
P/E Ratio
$4.18
$22.68
Revenue Growth
2.75
3.70
52 Week Low
$23.18
$24.05
52 Week High
$40.26
$41.24

Technical Indicators

Market Signals
Indicator
RCI
RPRX
Relative Strength Index (RSI) 44.04 57.50
Support Level $37.42 $39.24
Resistance Level $39.25 $40.50
Average True Range (ATR) 0.65 0.91
MACD -0.16 -0.08
Stochastic Oscillator 8.47 76.02

Price Performance

Historical Comparison
RCI
RPRX

About RCI Rogers Communication Inc.

Rogers Communications is the largest wireless service provider in Canada with more than 11 million subscribers, equating to one-third of the total Canadian market. Rogers' wireless business accounts for more than half of total revenue and has been growing at a higher rate than other segments. The cable segment, which provides about 38% of total revenue after acquiring Shaw, offers home internet, television, and landline phone service to consumers and businesses. Remaining sales come from Rogers' media unit, which owns and operates various television and radio stations and the Toronto Blue Jays. Rogers' significant exposure to sports also includes ownership stakes in the Maple Leafs, Raptors, Toronto FC, and Argonauts.

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Share on Social Networks: